All companies
Abbott Laboratories logo

What smart money is saying about Abbott LaboratoriesUnited States flag

ABT · Healthcare · Medical - Devices · Market cap $152.89B

5 funds in our archive have pitched Abbott Laboratories — most recently Acatis in August 2026.

Company profile

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Get an email when a fund writes about it

Summarize with Warren AI
6
Reported positions
1
Bought
2
Sold
11
Letters

Position history

Between Q4 2025 and Q3 2026, 6 fund letters reported a position in Abbott Laboratories1 opened or added to the position, 2 trimmed or exited.

Fund letters reporting a position in Abbott Laboratories, by quarter
QuarterLettersBoughtSoldTheses
Q3 20260001
Q2 20266120
Q1 20260003
Q4 20250001

Fund activity · 6 positions · 3 moves

Fund coverage · 5 theses

  • Acatis
    August 2026

    Abbott Laboratories is a diversified health care leader with recurring growth, competitive advantages and an attractive valuation.

    Read the full thesis
  • The Davenport Funds
    March 2026

    Abbott Laboratories is a diversified healthcare company with an expanded diagnostics market, accelerating growth guidance, and insider buying.

    Read the full thesis
  • Abbott Laboratories is a diversified healthcare 'Dividend King' with insider-supported value and upside from Exact Sciences’ MCED integration.

    Read the full thesis
  • Abbott Laboratories is a diversified medtech leader with catalysts in Libre and PFA, enhanced oncology diagnostics, and an attractive entry after de-rating.

    Read the full thesis
  • Abbott Laboratories offers durable growth from leadership in diabetes, heart health, and electrophysiology, supported by innovation and a diversified global model.

    Read the full thesis

Read every full thesis on Abbott Laboratories

Unlock all 5 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger